Biomark Diagnostics Inc. — Form D
Biomark Diagnostics Inc. of RICHMOND, A1, a company, filed a Form D exempt-offering notice with the SEC on 2025-04-14. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-04-14
- Form: D
- Accession: 0002064257-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 10
- Date of first sale: 2025-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-543611
Issuer
- Name: Biomark Diagnostics Inc.
- CIK: 0002064257
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 130 - 3851 SHELL RD, RICHMOND, A1, V6X 2W2
- Phone: 604-370-0779
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Rashid Bux | Director | Richmond, A1 |
| Brian Kai-Ming Cheng | Director | Richmond, A1 |
| Bramhanand Ramjiawan | Director | Richmond, A1 |
| Rashid Bux | Executive Officer | Richmond, A1 |
| Guoyu Kai-Ming Huang | Executive Officer | Richmond, A1 |
More